This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Reply to Letter to the Editor “Antiepileptic Drug Augmentation for Treatment-Resistant Depression”

Terence A. Ketter, Ann M. Callahan, and Robert M. Post

Published: August 15, 1997

Article Abstract

Letter to the Editor

Sir: We appreciate Dr. Feiner’s stimulating comments. We wish to clarify that the patient in our report1 was taking benzodiazepines (primarily alprazolam, but in some cases clonazepam) to control anxiety during several of the antidepressant trials, and in each case, tapering the benzodiazepine resulted in increased anxiety and depression. Thus, the nefazodone plus alprazolam combination was but one of several trials that combined antidepressants with drugs (benzodiazepines) having anticonvulsant properties.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 58

Quick Links: Depression (MDD)

Sign-up to stay
up-to-date today!


Already registered? Sign In

Original Research

Effect of Zuranolone on Concurrent Anxiety and Insomnia Symptoms in Women With Postpartum Depression

Zuranolone was associated with improvements in depressive and anxiety symptoms and was beneficial for insomnia and patient-perceived...